Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Y Hu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppressionShuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
JCI Insight|June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemiaEileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Cell Reports|July 20, 2022
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivityChi-Ling Chiang, Eileen Y Hu, Lingqian Chang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppressionShuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
JCI Insight|June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemiaEileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Cell Reports|July 20, 2022
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivityChi-Ling Chiang, Eileen Y Hu, Lingqian Chang, et al.
Pageof 1